]>
IRCT20180108038274N1 IRCT 2018-04-19 Sabzevar University of Medical Sciences Efficacy of a oil Containing Chamomile in the Treatment Atopic Dermatitis Efficacy of a oil Containing Chamomile in the Treatment of Mild to Moderate Atopic Dermatitis: A Randomized, Double-blind controlled Trial 2018-03-20 anticipated 52 Complete https://irct.ir/trial/28837 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization method: The samples were randomly assigned sequences of quadrilateral blocks determined by the statistic consultant and the patients admitted to the clinic, respectively, in the two groups of intervention (local chamomile oil) and the control group (oserin). In A double-blind study that can distract the test result is hidden from both the patient and the researcher's point of view in clinical and therapeutic work. In most cases, double-blind testing is performed to achieve a higher scientific standard, Blinding description: In order to double the study, oil was prepared in similar packages of the same shape and randomly assigned to each of the packages. 2 Atopic dermatitis. Intervention 1: Intervention group:Chamomile oil twice a day for 14 days. Intervention 2: Control group:Oceerin twice a day for 14 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Neda Sirghani
Besid of the Sabzevar Route Police - Girl's Dormitory at Sabzevar University of Medical Sciences
Sabzevar Iran (Islamic Republic of) 9613873136 +98 51 4426 4588 nedasirghani@yahoo.com Sabzevar University of Medical Sciences scientific Dr. Aqiyullah Kikhosrowi
Asrar Street, Hashamtay Specialty Hospital
Sabzevar Iran (Islamic Republic of) 9613873136 +98 51 4401 1600 dr.keykhosravi@yahoo.com Sabzevar University of Medical Sciences Iran (Islamic Republic of) Infants with atopic dermatitis (based on SCORAD criteria and pediatrician diagnosis) Good birth weight for age Lack of underlying diseases and congenital disorders. Inclination mother's cooperation With the plan no limit 1 year Both Major medical diseases (immunodeficiency, growth and development disorders, genetic disorders) The presence of skin lesions other than eczema in the areas of topical application of the drug Use of medications that affect eczema during maternal or infant use Cancellation of the patient to continue the study L20.9 Atopic dermatitis, unspecified Treatment - Drugs Treatment - Drugs Intervention group:Chamomile oil twice a day for 14 days Control group:Oceerin twice a day for 14 days The severity of the involvement of dermatitis. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire and with SCORAD criteria for atopic dermatitis. The dryness, redness and irritation. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire. Pruritus rate. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire. Insomnia and restlessness of infants. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire. Quality of Life. Timepoint: Before starting treatment and days 6, 13 and 27. Method of measurement: questionnaire. Sabzevar University of Medical Sciences Approved 2018-02-18 Ethics Committee of Sabzevar University of Medical Sciences and Health Services University of Sabzevar, University of Tabriz, Sabzevar University of Medical Sciences and Health Services Sabzevar Razavi Khorasan Iran (Islamic Republic of)